A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
Public ClinicalTrials.gov record NCT01396213. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A randomized, double-blind, placebo-controlled Phase 2B study to evaluate the efficacy and safety of Larazotide Acetate in the treatment of patients with celiac disease who have persistent symptoms despite being on a gluten-free diet.
Study identification
- NCT ID
- NCT01396213
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 342 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 7, 2011 (Actual)
- Primary completion
- Aug 20, 2013 (Actual)
- Completion
- Aug 20, 2013 (Actual)
- Last update posted
- Sep 20, 2017
2011 – 2013
United States locations
- U.S. sites
- 56
- U.S. states
- 31
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35209 | — |
| Not listed | Mesa | Arizona | 85206 | — |
| Not listed | Tucson | Arizona | 85704 | — |
| Not listed | Oceanside | California | 92056 | — |
| Not listed | Orange | California | 92868 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | Santa Monica | California | 90404 | — |
| Not listed | Walnut Creek | California | 94598 | — |
| Not listed | Denver | Colorado | 80222 | — |
| Not listed | Boynton Beach | Florida | 33426 | — |
| Not listed | Edgewater | Florida | 32132 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Summerfield | Florida | 34491 | — |
| Not listed | Marietta | Georgia | 30067 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Rockford | Illinois | 61107 | — |
| Not listed | West Des Moines | Iowa | 50266 | — |
| Not listed | Wichita | Kansas | 67207 | — |
| Not listed | Lexington | Kentucky | 40536 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Baltimore | Maryland | 21229 | — |
| Not listed | Hagerstown | Maryland | 21742 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Chesterfield | Michigan | 48047 | — |
| Not listed | Wyoming | Michigan | 49519 | — |
| Not listed | Duluth | Minnesota | 55805 | — |
| Not listed | Rochester | Minnesota | 55905 | — |
| Not listed | Jackson | Mississippi | 39202 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | Missoula | Montana | 59808 | — |
| Not listed | Las Vegas | Nevada | 89119 | — |
| Not listed | Marlton | New Jersey | 08053 | — |
| Not listed | Lake Success | New York | 11042 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | Rochester | New York | 14618 | — |
| Not listed | Cary | North Carolina | 27518 | — |
| Not listed | Salisbury | North Carolina | 28144 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Mentor | Ohio | 44060 | — |
| Not listed | Oklahoma City | Oklahoma | 73160 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Bethlehem | Pennsylvania | 18017 | — |
| Not listed | Perkasie | Pennsylvania | 18944 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Pittsburgh | Pennsylvania | 15243 | — |
| Not listed | Warwick | Rhode Island | 02886 | — |
| Not listed | Chattanooga | Tennessee | 37421 | — |
| Not listed | Dallas | Texas | 75321 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Salt Lake City | Utah | 84109 | — |
| Not listed | St. George | Utah | 84790 | — |
| Not listed | Alexandria | Virginia | 22304 | — |
| Not listed | Charlottesville | Virginia | 22911 | — |
| Not listed | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01396213, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 20, 2017 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01396213 live on ClinicalTrials.gov.